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Mutations of genes in the renin-angiotensin system are
associated with congenital abnormalities of the kidney and
urinary tract. The major signaling pathway for branching
morphogenesis during kidney development is the c-Ret
receptor tyrosine kinase whose ligand is GDNF and whose
downstream target is Wnt11. We determined whether
angiotensin II, an inducer of ureteric bud branching in vitro,
influences the GDNF/c-Ret/Wnt11 pathway. Mouse
metanephroi were grown in the presence or absence of
angiotensin II or an angiotensin type 1 receptor (AT1R)
antagonist and gene expression was measured by whole
mount in situ hybridization. Angiotensin II induced the
expression of c-Ret and Wnt11 in ureteric bud tip cells. GDNF,
a Wnt11-regulated gene expressed in the mesenchyme, was
also upregulated by angiotensin II but this downregulated
Spry1, an endogenous inhibitor of Ret tyrosine kinase activity
in an AT1R-dependent manner. Angiotensin II also decreased
Spry1 mRNA levels in cultured ureteric bud cells. Exogenous
angiotensin II preferentially stimulated ureteric bud tip cell
proliferation in vivo while AT1R blockade increased cell
apoptosis. Our findings suggest AT1R-mediated inhibition of
the Spry1 gene increases c-Ret tyrosine kinase activity leading
to upregulation of its downstream target Wnt11. Enhanced
Wnt11 expression induces GDNF in adjacent mesenchyme
causing focal bursts of ureteric bud tip cell proliferation,
decreased tip cell apoptosis and branching.
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The metanephros develops by reciprocal inductive interac-
tions among the ureteric bud (UB), the metanephric
mesenchyme (MM), and the stroma.1–3 Branching morpho-
genesis involves UB outgrowth from the nephric duct
followed by repetitive branching to form the renal collecting
system (ureters, pelvis, calyces, and collecting ducts). In turn,
emerging UB tips induce surrounding mesenchymal cells to
form nephrons (from the glomerulus to the distal tubule).
Even subtle decreases in the efficiency of UB branching result
in a profound decrease in nephron endowment.4 Decreased
nephron endowment is linked to hypertension and eventual
progression to chronic renal failure.5,6 In addition, aberrant
UB branching morphogenesis causes renal dysplasia, a
leading cause of chronic renal failure in infants.7
The GDNF/c-Ret/Wnt11 signaling pathway is a major
positive regulator of UB branching in the metanephros.8
Glial-derived neurotrophic factor (GDNF) is released from
the MM and interacts with the c-Ret tyrosine kinase receptor
expressed in the UB tip cells to induce branching.9 GDNF/
c-Ret and Wnt11 cooperate genetically to induce branching
morphogenesis.10 Uncontrolled activation of the GDNF/
c-Ret/Wnt11 pathway is prevented by Sprouty (Spry) proteins
that function as intracellular inhibitors of receptor tyrosine
kinase (RTK) signaling.11 Genetic inactivation of Spry1 in
mice results in ectopic UB outgrowth from the Wolffian duct,
increased number of UB branches, and expanded GDNF,
c-Ret, and Wnt-11 expression domains,11,12 indicating that
Spry1 is a negative regulator of the GDNF/c-Ret/Wnt11
pathway.
Exposure to angiotensin-converting enzyme (ACE) in-
hibitors or angiotensin type 1 receptor (AT1R) antagonists
during fetal life, as well as mutations in the genes encoding
angiotensinogen, renin, ACE, or AT1R in humans are
associated with renal tubular dysgenesis.13 Inactivation of
the renin–angiotensin system genes in mice causes abnorm-
alities in the development of the ureter, renal pelvis, and
papilla.14–18 Angiotensinogen-, renin-, ACE-, or AT1R-
deficient mice exhibit pelvic dilation (hydronephrosis) and
a small papilla. Mutations in the AT2R gene are associated
with increased incidence of lower urinary tract anomalies
including double ureters and vesicoureteral reflux.19 These
findings indicate that UB growth and development is a major
target for angiotensin (Ang) II actions.
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We have recently reported that Ang II, acting via the AT1R,
stimulates UB branching morphogenesis in the intact
metanephric kidney cultured in vitro, and that activation of
the epidermal growth factor (EGF) RTK activity is a critical
step in the signal transduction pathway downstream of the
AT1R leading to UB branching.
20 We report here that Ang II
stimulates the GDNF/Ret/Wnt11 pathway indirectly by
repression of Spry1. This effect is accompanied by increased
proliferation of UB tip cells. Furthermore, inhibition of AT1R
signaling induces apoptosis preferentially in UB tip cells.
RESULTS
Effect of Ang II on c-Ret, Wnt11, and GDNF gene expression
in the ex vivo cultured metanephric kidney
The GDNF/c-Ret/Wnt11 signaling pathway is a major positive
regulator of UB branching morphogenesis program.8,21–23 In
a previous study, we demonstrated that Ang II stimulates UB
branching morphogenesis in E12.5 metanephric kidneys
grown ex vivo.20 In the present study, we examined whether
Ang II-induced UB branching is accompanied by activation
of the GDNF/c-Ret/Wnt11 pathway. Treatment with Ang II
(105 M) for 24 h increased c-Ret and Wnt11 mRNA
expression in the UB tip cells compared to control as
determined by in situ hybridization (ISH; Figure 1). GDNF
expression in the mesenchyme was also upregulated by Ang
II. These data suggest that activation of this signaling
pathway is critical in Ang II-mediated UB branching.20
Effect of Ang II on Spry1 gene expression in the ex vivo
cultured metanephric kidney and UB cells
Spry proteins function as intracellular inhibitors of RTK
signaling. Genetic inactivation of Spry1 in mice results in
increased number of UB branches, and expanded GDNF,
c-Ret, and Wnt-11 expression domains, indicating that Spry1
is a negative regulator of the GDNF/c-Ret/Wnt11 path-
way.11,12 We therefore examined whether Ang II stimulates
the GDNF/c-Ret/Wnt11 pathway indirectly by repression of
Spry1. E12.5 wild-type metanephroi were treated with media
or Ang II (105 M) for 24 h and processed for whole-mount
ISH. As previously reported,11,12 Spry1 mRNA was expressed
in UB branches and to a lesser extent in condensing
mesenchyme (Figure 2). Ang II treatment downregulated
Spry1 expression in the UB and surrounding mesenchyme
(Figure 2). These findings indicate that Ang II is an
important regulator of Spry1 in the intact metanephros.
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Figure 1 | Angiotensin (Ang) II upregulates c-Ret, Wnt11, and GDNF mRNA expression in E12.5 mouse metanephroi that were grown
ex vivo for 24 h. After 24 h in culture, kidney explants were processed for whole-mount in situ hybridization. Representative images
demonstrate that treatment with Ang II increased c-Ret and Wnt11 expression in the UB tips and GDNF expression in the mesenchyme.
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Figure 2 | Angiotensin (Ang) II downregulates Spry1 mRNA
expression in E12.5 mouse metanephroi that were grown ex
vivo for 24 h. After 24 h in culture, kidney explants were
processed for whole-mount in situ hybridization. Representative
images demonstrate that treatment with Ang II (105 M, b)
decreases Spry1 mRNA expression in the UB and in the
mesenchyme compared to control (media, a). AT1R antagonist
candesartan (d) abrogates Ang II-induced decrease in Spry1 gene
expression (c, d). (c) Ang II alone (105 M); (d) Ang II
(105 M)þ candesartan (105 M).
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To confirm the observed effect of Ang II on Spry1 and to
allow a more quantitative analysis of changes in Spry1 gene
expression, we examined the effect of Ang II on Spry1 mRNA
levels in cultured UB cells by quantitative real-time reverse-
transcription polymerase chain reaction. Treatment of UB
cells with Ang II (105 M) for 24 h resulted in a decrease of
Spry1 mRNA levels compared to control (0.66±0.03 vs
1.0±0.01, Po0.01; n¼ 3 per treatment group). We recently
demonstrated that cultured UB cells maintain expression of
Ang II AT1R mRNA.
24 Our present findings that Ang II
downregulates Spry1 mRNA expression in the UB cell lineage
indicate that Ang II-mediated inhibition of Spry1 gene
expression may be involved in Ang II-induced UB branching.
To examine the role of endogenous Ang II in the
regulation of Spry1, we utilized the AT1R antagonist,
candesartan. Treatment of E12.5 metanephroi with cande-
sartan (106 M) for 24 h abrogated Ang II-induced down-
regulation of Spry1 gene expression (Figure 2). The
inhibitory effects of endogenous Ang II on Spry1 gene
expression are therefore mediated by AT1R. As candesartan
treatment decreases UB branching,20 AT1R-mediated effect
on Spry1 is physiologically important.
Effect of Ang II on UB cell proliferation in the ex vivo cultured
embryonic kidney
To begin to understand the cellular events leading to
stimulation of UB branching by Ang II, we examined the
direct effects of Ang II on proliferation of the UB epithelium
utilizing 5-bromo-2-deoxyuridine (BrdU) incorporation as
an index of DNA synthesis in vivo. Treatment with Ang II
(105 M) for 48 h increased cell proliferation index in the UB
tip cells (28.5±2.4 vs 9.7±1.2, Po0.001) but not in UB
stalks (11.3±1.9 vs 9.3±1.2, P¼ 0.4) as compared to control
(Figure 3). These results demonstrate a preferential stimula-
tory effect of Ang II on UB cell proliferation in the tip cells
and are consistent with the notion that growth factor-
induced stimulation of UB branching is initiated by focal
bursts of tip cell proliferation.
AT1R blockade promotes apoptosis in metanephric kidneys
Aberrant apoptosis is a cardinal feature of renal dysplasia and
hypoplasia.25 Genetic inactivation of angiotensinogen, renin,
ACE, or AT1R in mice causes hypoplasia of the medulla and
papilla,14–18 which may be a result of excessive cell death in
the UB derivatives. Accordingly, we examined the effect of
AT1R antagonism on UB cell apoptosis in metanephroi
grown ex vivo. Treatment of E13.5 metanephroi with
candesartan (106 M) for 24 h significantly increased the
number of terminal uridine triphosphate (UTP) end-labeling
(TUNEL)-positive cells in the UB tips but not in the stalks
(tips: 0.12±0.08 vs 0.65±0.2, Po0.05; stalks: 0.88±0.19 vs
1.0±0.25, P¼ 0.72; Figure 4). These findings indicate a
preferential inhibitory role of endogenous Ang II and its
AT1R on apoptosis in UB tip cells, suggesting a role for
endogenous Ang II in epithelial cell survival during UB
branching morphogenesis.
DISCUSSION
The present study demonstrates that Ang II stimulates GDNF,
c-Ret, Wnt-11 gene expression, while inhibiting expression of
Spry1 in the metanephric kidney cultured in vitro. This effect
of Ang II on Spry1 is mediated by the AT1R. In addition,
Ang II induces preferential proliferation and provides a
survival signal to UB tip cells.
We recently reported that Ang II, acting via the AT1R,
stimulates UB branching morphogenesis in the metanephric
kidney cultured in vitro.20 Furthermore, we found that
activation of the EGF RTK activity is a critical step in the
signal transduction pathway downstream of the AT1R leading
to UB branching.20 These results indicated that Ang II can
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Figure 3 | Angiotensin (Ang) II stimulates proliferation of the ureteric bud (UB) tip cells. Ang II-treated metanephroi (b, d) have
more BrdU-positive cells (brown staining, arrows) in UB tips compared to control (media, a, c). (e) Ang II increases cell proliferation index in
UB tip but not in stalk cells.
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directly stimulate UB branching, and that cross-talk between
AT1R and RTK signaling is important in the development of
the renal collecting system.
c-Ret is an RTK that is activated by GDNF and is crucial in
UB morphogenesis in the developing kidney. GDNF is
expressed in the MM,26 whereas c-Ret is expressed along
the nephric duct and subsequently in the UB tip cells.9
Genetic inactivation of c-Ret or GDNF in mice leads to a
complete absence of the UB or significant impairment of UB
morphogenesis.21,22 Like c-Ret, Wnt11 is expressed in the UB
tip cells and interacts genetically with GDNF/c-Ret pathway
to induce UB branching.10 Wnt11 expression is reduced in c-
Ret/ metanephroi, indicating that Wnt11 is a downstream
target gene of c-Ret. UB branching and GDNF expression is
decreased in Wnt11/ metanephroi, indicating that both
mesenchymal GDNF expression and UB tree morphogenesis
are dependent on Wnt11 signal from UB tip cells.10 Thus, the
GDNF/c-Ret/Wnt11 pathway is a positive feedback loop that
acts to stimulate proliferation of UB tip cells and thus
promote further UB growth and branching. Our present
findings that Ang II enhances GDNF, c-Ret, and Wnt11
expression indicate that activation of this pathway by Ang II
is important in Ang II-mediated signaling to stimulate UB
tree morphogenesis.
RTK signaling is tightly controlled by positive and
negative regulators. Spry proteins function as intracellular
inhibitors of RTK signaling.27 Genetic inactivation of Spry1
in mice results in increased number of UB branches, and
expansion of GDNF, c-Ret, and Wnt-11 expression do-
mains.11,12 Therefore, Spry1 is a physiological negative
regulator of the GDNF/c-Ret/Wnt11 pathway. In the present
study, we found that exogenous Ang II suppresses Spry1 gene
expression in cultured embryonic kidneys. Thus, Ang II may
stimulate the GDNF/c-Ret/Wnt11 pathway indirectly by
repression of Spry1. Moreover, Ang II-induced downregula-
tion of Spry1 expression is abrogated by AT1R antagonism.
On the basis of these findings, we propose that AT1R
signaling negatively regulates Spry1 gene expression. This in
turn facilitates c-Ret RTK signaling leading to activation of
the GDNF/Ret/Wnt11 positive feedback loop (Figure 5). The
mechanism of AT1R-Spry1 interactions may involve cluster-
ing in lipid rafts. Caveolae/lipid rafts are essential for Ang II-
induced transactivation of EGF receptor.28 We have demon-
strated that activation of AT1R by Ang II induces tyrosine
phosphorylation of EGF receptor in UB cells.20 As Spry
proteins rapidly translocate to lipid rafts following stimula-
tion with EGF,29 AT1R activation by Ang II may hinder
association of Spry1 with RTK (EGF receptor, c-Ret) to
prevent inhibition and stimulate UB branching.
The balance of cell proliferation and apoptosis is
important in UB branching and nephron endowment.30–35
Derangements of the regulatory mechanisms that control
these events are implicated in the pathogenesis of renal
hypodysplasia,25,34 a leading cause of pediatric end-stage
renal disease.7 The present study demonstrates that Ang II
causes preferential proliferation of UB tip cells, whereas
inhibition of endogenous AT1R signaling inhibits UB tip cell
apoptosis. As Ang II stimulates UB tip cell proliferation and
both c-Ret and Wnt11 are expressed in the UB tip cells, it is
likely that observed increase in Ret and Wnt11 expression by
Ang II is due to in part enhanced UB tip cell proliferation. We
speculate that Ang II induces focal bursts of proliferation of
UB tip cells, and together with decreased apoptosis, plays an
important role in the expansion of the ampulla, subsequent
branching, and directional bud elongation.
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Figure 4 | The AT1R antagonist, candesartan, stimulates
apoptosis in UB tip cells. Apoptotic cells were identified by
TUNEL (brown staining). (a) Media, (b) candesartan (106 M),
(c) kidney treated with TACS-nuclease to generate DNA breaks in
every cell (positive control); (d) bar graph shows the effect of
media or candesartan on the number of TUNEL-positive cells in
the UB tip and stalk cells. G, glomerulus; UB, ureteric bud; ND, not
different. (b) TUNEL-positive cells in UB are indicated by arrows.
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Figure 5 | A proposed model for Ang II-induced UB branching
morphogenesis. Ang II AT1R-mediated inhibition of Spry1 gene
expression releases c-Ret tyrosine kinase activity leading to
upregulation of c-Ret and its downstream target gene, Wnt-11.
Enhanced Wnt-11 expression, in turn, induces GDNF expression in
the adjacent mesenchyme. This causes focal bursts of UB tip cell
proliferation and branching. Decreased UB tip cell apoptosis may
also contribute to Ang II-induced UB branching. The mechanisms
of Spry1 inhibition by Ang II remain to be determined.
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The mechanisms by which Ang II regulates UB tip cell
proliferation and apoptosis are not known. Potential
mechanisms include upregulation of antiapoptotic (Bcl-2)
and downregulation of proapoptotic (bax, p53) factors. In
this regard, decreased UB branching is observed in Bcl-2/
mice.35 Moreover, Bcl-2 overexpression in the UB suppresses
UB cell apoptosis, stimulates branching of the UB tree, and
increases nephron endowment.34 The finding that p53 or bax
inactivation rescues both aberrant apoptosis and UB
branching in salt-stressed bradykinin B2 receptor-null mice36
provides further evidence that G-protein-coupled receptor
signaling is intimately linked to cell survival in the
metanephric kidney. Stimulation of AT1R by Ang II increases
intracellular calcium and activates protein kinase C.37
Activation of the extracellular signal-regulated kinase/mito-
gen-activated protein kinase pathway by protein kinase C
stimulates transcription of cell-cycle progression genes, such
as cyclin D1, through activation of the transcription factor
AP-1.38 Ang II may regulate these pathways directly or may
favor the release of a mesenchymal factor, such as GDNF,
which, in turn, stimulates UB tip cell proliferation30,31 and
migration.39,40 Recent data indicate that GDNF-induced
migration of Ret-transfected MDCK cells is critically
dependent on Ret and its downstream signaling via the PI3
kinase pathway.39,40 We propose a model in which stimula-
tion of GDNF and c-Ret by Ang II induces preferential
proliferation and survival of UB tip cells leading to UB
growth and branching (Figure 5).
In summary, the present study demonstrates that Ang II,
acting via the AT1R, downregulates Spry1 and upregulates
GDNF/Ret/Wnt11 gene expression in the metanephros. The
stimulatory effects of Ang II on the GDNF/Ret/Wnt11
pathway are accompanied by preferential proliferation and
survival of UB tip cells. These results support the hypothesis
that abnormal collecting system development in angiotensi-
nogen-, renin-, ACE- or AT1R-deficient mice is at least partly
due to dysregulation of the UB branching morphogenesis
program as well as aberrant UB cell proliferation and
apoptosis.
MATERIALS AND METHODS
Metanephric organ culture
Wild-type CD1 mice embryos (Charles River Laboratories, New
York, NY) were dissected aseptically from the surrounding tissues
on E12. 5 and the metanephroi were isolated. The day when the
vaginal plug was observed was considered to be E0.5. Metanephroi
were grown on air–fluid interface on polycarbonate transwell
filters (Corning Costar, 0.5 mm) inserted into six-well plates
containing Dulbecco’s modified Eagle’s medium/F12 medium
(Gibco BRL, Carlsbad, CA, USA) alone or in the presence of Ang
II (105 M) alone or combined with the AT1 receptor (AT1R)
antagonist candesartan (106 M; Sigma, St Louis, MO, USA) for 24 h
at 37 1C and 5% CO2
20 and then processed for the whole-mount
ISH. The effect of drug treatment was studied in paired kidneys
obtained from the same fetus (that is, left kidney was incubated with
media and right kidney with Ang II or left kidney with media and
right kidney with candesartan).
In situ hybridization
The effect of Ang II on the GDNF/c-Ret/Wnt11 pathway during UB
branching was examined by whole-mount ISH. c-Ret, GDNF,
Wnt11, and Spry1 cDNAs were kind gifts from Dr F. Costantini,
Dr A. McMahon, and Dr J.D. Licht, respectively. Preparation of
RNA probes and whole-mount ISH were performed according to
protocols (http://www.hhmi.ucla.edu/derobertis/protocol_page/mouse.
PDF) established in the De Robertis Laboratory. Five embryonic
kidneys per treatment group per probe were examined. All experiments
were done at least twice. The metanephroi were photographed using an
Olympus model SC35 camera mounted on an Olympus model BH-2
microscope, and digital images were captured using Adobe Photoshop
software.
Quantitative real-time reverse-transcription polymerase
chain reaction
Quantitative real-time reverse-transcription polymerase chain reac-
tion was utilized to determine whether Ang II alters c-Ret, Wnt11,
and Spry1 mRNA expression in UB cells (generously provided by Dr
Jonathan Barasch, Columbia University). We have previously
demonstrated that these cells express AT1R mRNA (Iosipiv, 2003).
UB cells were grown in MEM medium (Gibco BRL) that contained
10% fetal bovine serum at 37 1C in an incubator with 5% CO2. Cells
were starved overnight and treated with media (control, n¼ 3) or
Ang II (106 M, n¼ 3) for 24 h at 37 1C and 5% CO2. The cells were
used at passages 5–8. Total RNA was extracted using the TRIzol
reagent (Invitrogen, Carlsbad, CA, USA). RNA (3mg) was reverse-
transcribed in the presence of 100 ng random hexamers, 0.001 ml of
10 mM dNTP, 0.002 ml of 10 RT buffer (200 mM Tris-HCl (pH
8.4), 500 mM KCl, 15 mM MgCl2), and 200 U of Superscript II reverse
transcriptase (Invitrogen) as previously described.24
SYBR Green quantitative real-time reverse-transcription poly-
merase chain reaction was conducted in the Mx3000P equipment
(Stratagene, La Jolla, CA) using MxPro QPCR software (Stratagene).
Mouse Spry1 gene-specific primers obtained from SuperArray
(Frederick, MD). Each PCR reaction was run in 25 ml with the
12.5ml SYBR Green ER qPCR SuperMix (Invitrogen), 1 ml first-
strand cDNA template and 1 ml primer set (10 mM each). The
program conditions were: 95 1C, 10 min followed by 40 cycles of
95 1C, 15 s and 60 1C, 1 min. The quantity of each target mRNA
expression was normalized by that of glyceraldehyde-3-phosphate
dehydrogenase mRNA expression. Three UB cell RNA samples per
treatment group were analyzed in duplicates in each run. PCR
reaction was performed twice.
Cell proliferation and apoptosis assays
To examine the role of cell proliferation in Ang II-induced UB
branching, we examined the effect of exogenous Ang II on in vivo
incorporation of BrdU. CD1 mice metanephroi isolated on E11.5
were grown on filters in the presence of Ang II (105 M, n¼ 4) or
Dulbecco’s modified Eagle’s medium/F12 medium alone (control,
n¼ 4) for 48 h at 37 1C. BrdU (104 M; Sigma) was added to the
media during the last 6 h of incubation. The kidneys were fixed in
10% neutral buffered formalin overnight at 4 1C, processed for
paraffin embedding, and 4-mm-thick sections were cut. Slides were
deparaffinized in two exchanges of xylene and rehydrated in a series
of graded ethanol. After quenching of endogenous peroxidase with
30% H2O2 and trypsin digestion, the sections were treated with
blocking solution and sequentially incubated with biotinylated
mouse anti-BrdU antibody (Sigma; 1:50), streptavidin-peroxidase
substrate, and stained with diaminobenzidine (Zymed, San
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Francisco, CA). The slides were counterstained with hematoxylin,
mounted, and coverslipped. The number of BrdU-positive (brown)
and -negative (blue) cells was determined in four randomly selected
UBs of each kidney section by light microscopy. Cell proliferation
index (percentage of BrdU-positive cells) was calculated from the
ratio of BrdU-positive to total nuclei.
To investigate the role of endogenous Ang II and AT1R in UB cell
apoptosis, E12.5 CD1 mice metanephroi were grown on filters in the
presence of Dulbecco’s modified Eagle’s medium/F12 medium alone
(n¼ 10) or with AT1R antagonist candesartan (106 M, n¼ 10) for
24 h at 37 1C. Apoptosis was assessed by TUNEL (TACS TdT Kit;
R&D Systems, Minneapolis, MN). Following digestion with
20 mg/ml proteinase K for 15 min at room temperature, the sections
were peroxidase quenched with 30% H2O2, and the TUNEL labeling
reaction mixture was added to cover each section. The slides were
then incubated in a humidified chamber for 60 min at 37 1C. The
reaction was stopped by a stop buffer. The slides were counter-
stained with 0.5% methyl green and examined by light microscopy.
The number of TUNEL-positive cells per UB tip or stalk was
determined in each kidney section (n¼ 10 kidneys per group; three
sections per kidney) and the mean number of TUNEL-positive cells
per UB tip or stalk was calculated.
Statistical analysis
Differences among the treatment groups in Spry1 mRNA levels and
the number of BrdU- and TUNEL-positive cells in media vs Ang II
or candesartan vs Ang II were analyzed by Student’s t-test. A P-value
of o0.05 was considered statistically significant.
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